investment.com

Rapport Therapeutics, Inc. — insider transactions

7 transactions on record · RAPP · CIK 2012593

Aggregates

computed from the filings below
Purchases, 12m
0
count of open-market buys
Sales, 12m
7
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
1
Bought, 3m
$0
Sold, 3m
$1.7M
Median disclosure lag
1.0 d
trade date to filing date
Largest single trade, 24m
$938K
2026-08-25
Director share, 12m
100.0%
of transactions where role is stated
Current run
7 sells
consecutive same-direction transactions
Net 3m flow
-$1.7M
purchases minus sales
Total on record
7

Transactions

7 most recent shown
DisclosedTradedLag, dInsiderRoleTransactionSharesPriceValueSource
2026-09-092026-09-081Ceesay AbrahamDirector, Chief Executive OfficerOpen market sale7,141$45.56$325.3Kfiling
2026-09-092026-09-081Ceesay AbrahamDirector, Chief Executive OfficerOpen market sale1,069$46.01$49.2Kfiling
2026-08-262026-08-251Ceesay AbrahamDirector, Chief Executive OfficerOpen market sale18,921$49.57$938Kfiling
2026-07-292026-07-272Ceesay AbrahamDirector, Chief Executive OfficerOpen market sale7$42.74$299.1filing
2026-07-292026-07-272Ceesay AbrahamDirector, Chief Executive OfficerOpen market sale2,203$42.11$92.8Kfiling
2026-07-152026-07-141Ceesay AbrahamDirector, Chief Executive OfficerOpen market sale5,481$39.72$217.7Kfiling
2026-07-152026-07-141Ceesay AbrahamDirector, Chief Executive OfficerOpen market sale2,729$40.57$110.7Kfiling

Source: U.S. Securities and Exchange Commission, EDGAR

Rapport Therapeutics, Inc. insider transactions — 7 filings on record — investment.com